latest news releases from the newsroom
FindProfit.com Provides Earnings Preview for Select Portfolio Stocks
PRINCETON, N.J., July 22, 2003 (PRIMEZONE) -- FindProfit (www.findprofit.com), an investment advisory service that delivered a +73% audited return in 2002, announced today that it has provided to trial and paid subscribers a "what to look for" earnings preview on several of FindProfit's portfolio stocks which are reporting financial results this week. Two of the profiled stocks include AOL Time Warner (NYSE:AOL) and Activision (Nasdaq:ATVI).
Blyth, Inc. Estimates Second Quarter E.P.S.
GREENWICH, Conn., July 22, 2003 (PRIMEZONE) -- Blyth, Inc. (NYSE:BTH) (the "Company"), a worldwide leader in the home expressions marketplace, today announced that second quarter fiscal year 2004 earnings are anticipated to be below prior year and management's initial expectations across most of its business units and distribution channels in North America and Europe, reflecting weak economic conditions, as well as consumer and retailer caution, in its major markets. The Company's financial results for the quarter ending July 31, 2003 will be announced on August 27, 2003. Second quarter Earnings Per Share are expected to be $0.20 - $0.24. Earnings Per Share for the second quarter of fiscal year 2003 were $0.40.
Insert Therapeutics, Inc.
Insert Therapeutics Describes In Vivo Performance and Versatility of Drug Delivery Platform
PASADENA, Calif., Jul 22, 2003 (PRIMEZONE) -- Insert Therapeutics, Inc. President and Chief Executive Officer, Leonard R. Borrmann, Pharm.D., presented data today demonstrating the flexibility and distinct advantages of the company's proprietary Cyclosert(tm) drug delivery technology. First, Cyclosert provides a solution to the diverse challenges of systemic delivery for small-molecule drugs that, without delivery enhancement, have limited clinical effectiveness or unacceptable toxicity. Second, Cyclosert can be used to formulate, protect and systemically deliver nucleic acids, including plasmid DNA, RNA and oligonucleotides, into targeted cells with subsequent expression.
Catholic Schools Textbook Project
New Release: First History Textbook for Catholic Schools in Nearly 40 Years
LOS ANGELES, July 22, 2003 (PRIMEZONE) -- Imagine paying extra money to send your children to Catholic school and not having History textbooks with vignettes about saints or other relevant Catholic historical contributions. That has been the case for the past 40 years. Until now, Catholic schools have had to choose between using secular history textbooks or reproducing old, out-of-date history textbooks previously written for Catholic schools. But now that has changed.